Cosmos Health Inc. COSM NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

12/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cosmos Health Inc. (COSM) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 4.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -207.35%, forward earnings yield 20.96%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -207.35%).
Forward P/E 4.8 — analysts expect a return to profitability with estimated EPS of $0.07 for FY2027.
Trailing Earnings Yield -207.35% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 20.96% as earnings recover.

Overall SharesGrow Score: 11/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

12/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

33/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — COSM

Valuation Multiples

P/E (TTM)-0.5

Forward P/E4.8

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.39

P/S Ratio0.13

EV/EBITDA-1.9

Per Share Data

EPS (TTM)$-0.61

Forward EPS (Est.)$0.07

Book Value / Share$0.76

Revenue / Share$1.95

FCF / Share$-0.34

Yields & Fair Value

Earnings Yield-207.35%

Forward Earnings Yield20.96%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2015	-0.6	0.00	-3.22	7.53	-
2016	-6.6	0.07	-2.25	0.58	-
2017	-0.8	0.00	-1.71	0.17	-
2018	-0.2	-0.01	-0.64	0.06	-
2019	-0.4	0.01	-0.18	0.03	-
2020	3.3	-0.03	-0.65	0.05	-
2021	-0.3	0.00	0.51	0.04	-
2022	-0.6	-0.02	0.22	0.17	-
2023	-0.9	0.01	0.47	0.32	-
2024	-0.8	0.02	0.52	0.24	48.36%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-13.31	$533.8K	$-6.69M	-1252.9%
2016	$-1.20	$6.76M	$-601K	-8.9%
2017	$-12.25	$30.01M	$-6.21M	-20.7%
2018	$-17.02	$37.08M	$-9.06M	-24.4%
2019	$-6.21	$39.68M	$-3.3M	-8.3%
2020	$1.54	$55.41M	$820.79K	1.5%
2021	$-23.74	$56.24M	$-7.96M	-14.2%
2022	$-33.16	$50.35M	$-13.83M	-27.5%
2023	$-2.15	$53.38M	$-18.54M	-34.7%
2024	$-1.17	$54.43M	$-16.18M	-29.7%